Anil Rama
Sleep Medicine · Saratoga, CANPI 1518053131
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,988 of the $14,472 with a category attached, or 89.7%. It is spread thinly across 25 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,639, more than ten times the $470 reported in 2021.
Across 401 payments — averaging $36.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$3K
- Jazz Pharmaceuticals Inc.$2K
- Harmony Biosciences LLC$2K
- Avadel CNS Pharmaceuticals, LLC$1K
- Acadia Pharmaceuticals Inc$1K
- Fisher & Paykel Healthcare Inc$1K
- plus $4K from 19 others
What the payments were for
- Consulting fees$3873%
- Food & beverage$12,98890%
- Education$2472%
- Other$8506%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 98 | $2,946 |
| Jazz Pharmaceuticals Inc. | 49 | $1,757 |
| Harmony Biosciences LLC | 51 | $1,542 |
| Avadel CNS Pharmaceuticals, LLC | 48 | $1,466 |
| Acadia Pharmaceuticals Inc | 28 | $1,423 |
| Fisher & Paykel Healthcare Inc | 8 | $1,073 |
| Idorsia Pharmaceuticals US Inc | 30 | $597 |
| Itamar Medical Inc | 3 | $510 |
| Alkermes, Inc. | 11 | $444 |
| Teva Pharmaceuticals USA, Inc. | 9 | $411 |
| AbbVie | 16 | $385 |
| Resmed Corp | 12 | $377 |
| Vertex | 1 | $327 |
| Inspire Medical Systems, Inc. | 10 | $321 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $218 |
| Vanda Pharmaceuticals Inc. | 8 | $214 |
| Eisai Inc. | 3 | $165 |
| Sentynl Therapeutics, Inc. | 1 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Dexcom, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $39 |
| Noctrix Health, Inc. | 1 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Optinose US, Inc. | 1 | $19 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FISHER & PAYKEL HEALTHCARE$850
- NUPLAZID$847
- WatchPATONE$510
- LYBALVI$472
- Auvelity$364
- AUSTEDO$232
- XYWAV$139
- SUNOSI$120
- Dayvigo$113
- CAPLYTA$105
How this compares
$14,472 in reported general payments places this provider in the 85th percentile of 200 sleep medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 20 | $10,041 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Saratoga
- Lisa ShivesSan Diego$1.4M
- Haramandeep SinghSan Ramon$1.1M
- Atul MalhotraSan Diego$771K
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Sam KashaniSanta Monica$221K
- Emmanuel MignotStanford$135K
- Jerome HesterPalo Alto$74K
- Mark BuchfuhrerDowney$70K
- Clete KushidaStanford$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.